NOTCH3 and hepatocellular carcinoma: In this perspective, we already assessed whether the Notch3 expression, which is strongly deregulated in HCC, is responsible for the resistance to brivanib.9–11 By using a rat model of HCC, we found in this study that Notch3 depletion combined with brivanib treatment exerts a substantial antitumour effect in vivo.